Add Yahoo as a preferred source to see more of our stories on Google. As schools close out for the summer, a homegrown Georgia company is taking center stage in the race to prepare the next generation ...

For some academics, conference networking can be energizing — offering a chance to connect, learn from others and explore new ideas. But for others, the prospect of ‘schmoozing’ at a reception crowded ...

Foot discomfort can significantly impact daily routines and overall well-being. Signal Step is a drug-free wellness insert designed to help reduce foot discomfort. According to company data, many ...

Replaced Chapter 8 brings you back to Warren's Phoenix-City apartment to find anything that could help with REACH's current situation. Near the end of the chapter, there's a locked safe that you need ...

A Norwegian researcher has identified an issue with Microsoft Edge’s Password Manager that could be a serious concern for businesses. Tom Jøran Sønstebyseter Rønning found that passwords are being ...

11th May 2026: We updated our list of working Rivals codes. Rivals is a Roblox shooter with an impressively detailed weapon system. In this game, you’ll challenge other players to duels, shop for ...

Device code phishing attacks that abuse the OAuth 2.0 Device Authorization Grant flow to hijack accounts have surged more than 37 times this year. In this type of attack, the threat actor sends a ...

Step aerobics is a low impact, high intensity workout that may help improve functional movement; in translation, make the physical tasks in your everyday life easier. While there are platforms ...

EXCLUSIVE: The Age Of Adaline co-writer Salvador Paskowitz is teaming with business partner Timothy “Timo” Nelligan to launch microdrama outfit Super Punchy Studios. The company’s first vertical title ...

Beast Industries has acquired a banklike app for young people and could eventually offer a variety of financial services, including crypto. By Tara Siegel Bernard and Ron Lieber Jimmy Donaldson, the ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...